Quick Summary

Quassia amara is a plant known for its complex bioactive composition. Research into its pharmacological properties and potential medicinal applications is ongoing, but human clinical evidence remains limited. Some studies suggest potential benefits of bitter compounds (such as those found in Quassia) on reducing energy intake, which may have relevance in obesity management. Topical use of polyphenols, including from Quassia extracts, has been evaluated for skin conditions such as rosacea with some indications of symptom improvement. However, current evidence is insufficient to establish definitive clinical efficacy or safety in humans.

What Is It?

Quassia amara is a tropical plant species traditionally used for its bitter compounds. It belongs to the family Simaroubaceae and is native to Central and South America. The plant contains a variety of bioactive substances that have attracted interest for potential therapeutic use.

Traditional Uses

Traditionally, Quassia has been used in folk medicine as a bitter tonic to stimulate digestion, treat parasitic infections, and support general health. The bitter taste of quassinoids found in Quassia extracts has also been employed to promote appetite regulation and gastrointestinal function.

Active Compounds

Quassia amara contains bitter-tasting compounds known as quassinoids, which are a type of bioactive diterpenoid. It also includes polyphenols and other phytochemicals that may contribute to its observed effects.

Potential Benefits with Evidence Levels

  • Reduction in energy intake (potential role in weight management): Moderate evidence from human clinical studies involving bitter tastants (not specific to Quassia amara alone but relevant to its bitter constituents). A meta-analysis showed a significant reduction of energy intake by about 54.62 kcal in healthy volunteers following exposure to bitter tastants.
    Evidence level: Moderate; clinical trials available
  • Potential improvement in rosacea symptoms (facial erythema, papules, pustules): Limited evidence from small human clinical studies of topical applications containing quassia extracts. Some symptom reduction was observed, but these studies had significant methodological limitations.
    Evidence level: Limited; clinical trials available but small scale

Side Effects

No specific human clinical trial data on adverse effects of Quassia amara were identified in the available evidence. Toxicological properties may vary depending on preparation and extraction methods. Historical preclinical studies have raised concerns about potential hepatotoxicity at high doses, but these findings have not been confirmed in humans.

Drug Interactions

No direct evidence from clinical studies regarding drug interactions with Quassia amara is currently available.

Who Should Avoid It

Because of limited safety data, individuals who are pregnant or breastfeeding are advised to avoid Quassia amara or consult a healthcare provider before use. No specific contraindications have been clearly identified in human clinical evidence.

Evidence Limitations

Current evidence on Quassia amara is limited by several factors including small study sizes, lack of randomized controlled trials focused specifically on this plant, methodological weaknesses, and reliance on indirect evidence from bitter tastants generally rather than Quassia alone. The majority of human studies involve topical applications or are preclinical or ethnobotanical. More large-scale, rigorous clinical trials are needed to better establish its efficacy and safety profile.

References

Last Reviewed

June 2024

Informational Disclaimer

This content is for informational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always consult your healthcare professional before starting any new herbal product or therapy, especially if you have existing health conditions or are taking medications. The safety and efficacy of Quassia amara for specific health purposes have not been conclusively established.